保罗样激酶1蛋白在肝细胞癌中的表达及临床意义
孙威;陈爱山;殷红专;尹剑桥;闫兆鹏;刘宝林
【期刊名称】《中国医科大学学报》 【年(卷),期】2012(041)004
【摘要】Objective To investigate the expression and clinical significance of Polo-tike kinase 1 (Plk1) protein in hepatocellular carcinoma (HCC) tissues and the expression in hepatocellular carcinoma cell lines. Methods Immunohistochemical technique (SP) was used to detect the expression of the Plk1 protein in HCC tissues of 67 cases, 27 cases of corresponding paracancerous cinhosis tissues and 5 cases of normal tissues of liver. The relationship between clinical pathology characters and expression of the Plkl protein were analyzed as well. Western blot was used to detect the expression of the Plkl protein in hepatocellular carcinoma cell lines BCL-7402 and HepG2. Results The positive rate of Plk1 in HCC tissues was 76.1% and 44.8% of all carcinomas showed strong expression of Plk1. Twenty-seven cases of corresponding paracancerous cirrhosis tissues all showed positive expression. No significant Plk1 expression was observed in normal tissues of liver. The expression of Plkl protein in well differentiated HCC tissues was markedly higher than that of poor differentiation tissues (P < 0.01). In addition,HCC tissues with peplos encroachment showed lower expression rates than others without peplos encroachment (P<0.05).
There were no other significant correlations of Plk1 expression with either age,tumor diameter and quantity,lymphoid node metastasis, extia-hepatic metastasis,or portal vein embolus could be established. Plkl protein was found to be overexpressed in both hepatoeellular carcinoma cell lines. Conclusion These results demonstrated a higher rate of Plk1-positivity in HCC which suggested involvement of Plk1 in tumorige-nesis in this tumor entity and might be an important early event of this process. Therefore, targeted strategies focusing on Plkl inhibition might represent a promising new therapy approach in hepalucellular carcinoma.%目的 探讨肝细胞癌(HCC)组织及细胞系中保罗样激酶1(Plk1)蛋白的表达情况及其临床意义.方法 应用免疫组化SP法检测HCC组织67例、配对癌旁肝硬化组织27例反正常肝组织5例中Plk1蛋白的表达情况,并分析其与临床病理特征之间的关系.应用Western blot检测肝癌细胞系BCL-7402及HepG2细胞中Plk1蛋白的表达情况.结果 Plk1蛋白在HCC组织中的阳性表达率为76.1％(51/67),其中强阳性44.8％( 30/67),在配对的癌旁肝硬化组织中均呈阳性表达,而5例正常肝组织中均无明显表达.高分化HCC中Plk1蛋白的表达明显高于中、低分化HCC(P＜0.01)；无包膜侵犯的HCC组织中Plk1蛋白的表达高于有包膜侵犯的HCC组织(P＜ 0.05)；Plk1的表达与患者年龄、肿瘤直径、肿瘤数目、淋巴结转移、肝外转移及门静脉有无癌栓无关.肝癌细胞系BCL-7402及HepG2中均存在Plk1蛋白的过表达.结论 Plk1在HCC中表达率较高,其阳性表达可能是HCC发生过程中一个关键的早期因素. 【总页数】4页(325-328)
【关键词】肝细胞癌;病理学;细胞培养;保罗样激酶1 【作者】孙威;陈爱山;殷红专;尹剑桥;闫兆鹏;刘宝林
【作者单位】中国医科大学附属盛京医院结直肠、肛门病外科,沈阳110004;中国医科大学附属盛京医院结直肠、肛门病外科,沈阳110004;中国医科大学附属盛京医院结直肠、肛门病外科,沈阳110004;中国医科大学附属盛京医院结直肠、肛门病外科,沈阳110004;中国医科大学附属盛京医院结直肠、肛门病外科,沈阳110004;中国医科大学附属盛京医院结直肠、肛门病外科,沈阳110004 【正文语种】中文 【中图分类】R73 【文献来源】
https://www.zhangqiaokeyan.com/academic-journal-cn_journal-china-medical-university_thesis/0201246675798.html 【相关文献】
1.原发性肝细胞癌与胆管细胞癌中高尔基体蛋白73及甲胎蛋白表达的临床意义 [J], 孙景武; 刘志春; 张雷; 张龙; 张帆
2.尿激酶型纤溶酶原激活物、基质金属蛋白酶在肝细胞癌中的表达及其临床意义 [J], 林静; 廖芝玲; 罗殿中; 苏传丽
3.含植物同源结构和环指域泛素样蛋白1在肝细胞癌中的表达及其临床意义 [J], 林凯煌; 陈维荣; 蔡高阳
4.肝细胞癌中Kruppel样因子4与叉头框蛋白M1基因表达相关性及临床意义 [J], 田川; 叶庆旺; 姚姗姗; 高勇; 杨宁; 李琦
5.细胞外基质蛋白-1与基质金属蛋白酶-9在肝细胞癌中的表达及其临床意义
保罗样激酶1蛋白在肝细胞癌中的表达及临床意义
